{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:45:59Z","timestamp":1772599559395,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K15832"],"award-info":[{"award-number":["18K15832"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver function is a most important prognostic factor in patients with liver cirrhosis. Also, portal hypertension is a fatal complication of liver cirrhosis and variceal treatment is indispensable. However, changes of liver functions after endoscopic variceal treatments are unknown. The aim of this study was to evaluate prognosis and liver functions after endoscopic injection sclerotherapy (EIS) and endoscopic variceal ligation (EVL). A total of liver cirrhotic 103 patients who underwent prophylactic EIS and EVL were enrolled. Overall survival rate was higher in EIS group than EVL group (p\u2009=\u20090.03). Multivariate analysis showed that EIS was a negative factor for death (HR: 0.46, 95% confidence interval: 0.24\u20130.88, p\u2009=\u20090.02). Liver functions were assessed by blood test taken at before and 3\u00a0months after treatment. In EIS group, albumin and prothrombin time improved (p\u2009&lt;\u20090.01), leading to improvement of Child\u2013Pugh score, ALBI score and MELD score (p\u2009&lt;\u20090.05). However, these did not improve in EVL group. EIS was a significant factor related to the elevated value of albumin after treatment in linear regression analysis (estimated regression coefficient: 0.17, 95% confidence interval: 0.05\u20130.29, p\u2009=\u20090.005). These results revealed that EIS could improve liver functions and prognosis.<\/jats:p>","DOI":"10.1038\/s41598-021-99855-z","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T10:09:16Z","timestamp":1634206156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Endoscopic injection sclerotherapy improves liver function compared with endoscopic variceal ligation"],"prefix":"10.1038","volume":"11","author":[{"given":"Tsuguru","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Kumei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Oe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Honma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"99855_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.21907","volume":"46","author":"G Garcia-Tsao","year":"2007","unstructured":"Garcia-Tsao, G. et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 46, 922\u2013938 (2007).","journal-title":"Hepatology"},{"key":"99855_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/hepr.12357","volume":"45","author":"M Sato","year":"2015","unstructured":"Sato, M. et al. Variceal hemorrhage: Analysis of 9987 cases from a Japanese nationwide database. Hepatol. Res. 45, 288\u2013293 (2015).","journal-title":"Hepatol. Res."},{"key":"99855_CR3","doi-asserted-by":"crossref","unstructured":"T. Hayashi et al., Use of the serum Wisteria floribunda agglutinin-positive Mac2 binding protein as a marker of gastroesophageal varices and liver-related events in chronic hepatitis C patients. Diagnostics (Basel) 10 (2020).","DOI":"10.3390\/diagnostics10030173"},{"key":"99855_CR4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/hepr.13533","volume":"50","author":"N Tamaki","year":"2020","unstructured":"Tamaki, N. et al. Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis. Hepatol. Res. 50, 996\u2013999 (2020).","journal-title":"Hepatol. Res."},{"key":"99855_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao, G., Abraldes, J. G., Berzigotti, A. & Bosch, J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 65, 310\u2013335 (2017).","journal-title":"Hepatology"},{"key":"99855_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.1840070503","volume":"7","author":"S Kitano","year":"1987","unstructured":"Kitano, S., Koyanagi, N., Iso, Y., Higashi, H. & Sugimachi, K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7, 810\u2013815 (1987).","journal-title":"Hepatology"},{"key":"99855_CR7","first-page":"1517","volume":"21","author":"MC Hou","year":"1995","unstructured":"Hou, M. C. et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial. Hepatology 21, 1517\u20131522 (1995).","journal-title":"Hepatology"},{"key":"99855_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-8278(00)80064-1","volume":"32","author":"MC Hou","year":"2000","unstructured":"Hou, M. C., Lin, H. C., Lee, F. Y., Chang, F. Y. & Lee, S. D. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: Comparison of sclerotherapy and ligation. J. Hepatol. 32, 202\u2013208 (2000).","journal-title":"J. Hepatol."},{"key":"99855_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-2007-1004182","volume":"29","author":"D Baroncini","year":"1997","unstructured":"Baroncini, D. et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 29, 235\u2013240 (1997).","journal-title":"Endoscopy"},{"key":"99855_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s004649901045","volume":"13","author":"P Svoboda","year":"1999","unstructured":"Svoboda, P., Kantorova, I., Ochmann, J., Kozumplik, L. & Marsova, J. A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices. Surg. Endosc. 13, 580\u2013584 (1999).","journal-title":"Surg. Endosc."},{"key":"99855_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00535-013-0914-y","volume":"49","author":"N Tamaki","year":"2014","unstructured":"Tamaki, N. et al. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J. Gastroenterol. 49, 1495\u20131503 (2014).","journal-title":"J. Gastroenterol."},{"key":"99855_CR12","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000494844","volume":"8","author":"A Hiraoka","year":"2019","unstructured":"Hiraoka, A., Kumada, T., Michitaka, K. & Kudo, M. Newly proposed ALBI grade and ALBI-T score as tools for assessment of hepatic function and prognosis in hepatocellular carcinoma patients. Liver Cancer 8, 312\u2013325 (2019).","journal-title":"Liver Cancer"},{"key":"99855_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s005350300038","volume":"38","author":"M Kudo","year":"2003","unstructured":"Kudo, M., Chung, H. & Osaki, Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J. Gastroenterol. 38, 207\u2013215 (2003).","journal-title":"J. Gastroenterol."},{"key":"99855_CR14","doi-asserted-by":"crossref","unstructured":"Hayashi, T. et al., Antiplatelet therapy improves the prognosis of patients with hepatocellular carcinoma. Cancers (Basel) 12 (2020).","DOI":"10.3390\/cancers12113215"},{"key":"99855_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1872-034X.2008.00407.x","volume":"39","author":"M Kobayashi","year":"2009","unstructured":"Kobayashi, M. et al. Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. Hepatol. Res. 39, 31\u201339 (2009).","journal-title":"Hepatol. Res."},{"key":"99855_CR16","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1111\/j.1530-0277.2006.00285.x","volume":"31","author":"H Takahashi","year":"2007","unstructured":"Takahashi, H. et al. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis: Comparison with liver cirrhosis C. Alcohol Clin. Exp. Res. 31, S43-48 (2007).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"99855_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1872-034X.2007.00020.x","volume":"37","author":"H Ikeda","year":"2007","unstructured":"Ikeda, H. et al. Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C. Hepatol. Res. 37, 104\u2013112 (2007).","journal-title":"Hepatol. Res."},{"key":"99855_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1148\/radiol.2292021128","volume":"229","author":"L Annet","year":"2003","unstructured":"Annet, L. et al. Hepatic flow parameters measured with MR imaging and Doppler US: Correlations with degree of cirrhosis and portal hypertension. Radiology 229, 409\u2013414 (2003).","journal-title":"Radiology"},{"key":"99855_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2214\/ajr.176.3.1760667","volume":"176","author":"BE Van Beers","year":"2001","unstructured":"Van Beers, B. E. et al. Hepatic perfusion parameters in chronic liver disease: Dynamic CT measurements correlated with disease severity. AJR Am. J. Roentgenol. 176, 667\u2013673 (2001).","journal-title":"AJR Am. J. Roentgenol."},{"key":"99855_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1053\/jhep.2002.31722","volume":"35","author":"V Gulberg","year":"2002","unstructured":"Gulberg, V., Haag, K., Rossle, M. & Gerbes, A. L. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 35, 630\u2013634 (2002).","journal-title":"Hepatology"},{"key":"99855_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/hep.1840070527","volume":"7","author":"WW Lautt","year":"1987","unstructured":"Lautt, W. W. & Greenway, C. V. Conceptual review of the hepatic vascular bed. Hepatology 7, 952\u2013963 (1987).","journal-title":"Hepatology"},{"key":"99855_CR22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00535-013-0756-7","volume":"48","author":"H Takahashi","year":"2013","unstructured":"Takahashi, H. et al. Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy. J. Gastroenterol. 48, 1353\u20131361 (2013).","journal-title":"J. Gastroenterol."},{"key":"99855_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1006\/niox.2001.0373","volume":"5","author":"JM Schoen","year":"2001","unstructured":"Schoen, J. M., Wang, H. H., Minuk, G. Y. & Lautt, W. W. Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 5, 453\u2013464 (2001).","journal-title":"Nitric Oxide"},{"key":"99855_CR24","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.surg.2004.03.012","volume":"136","author":"S Marubashi","year":"2004","unstructured":"Marubashi, S. et al. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 136, 1028\u20131037 (2004).","journal-title":"Surgery"},{"key":"99855_CR25","first-page":"434","volume":"21","author":"M Nagino","year":"1995","unstructured":"Nagino, M. et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21, 434\u2013439 (1995).","journal-title":"Hepatology"},{"key":"99855_CR26","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/bjs.10153","volume":"103","author":"H Tranchart","year":"2016","unstructured":"Tranchart, H. et al. Liver regeneration following repeated reversible portal vein embolization in an experimental model. Br. J. Surg. 103, 1209\u20131219 (2016).","journal-title":"Br. J. Surg."},{"key":"99855_CR27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1046\/j.1440-1746.2003.03087.x","volume":"18","author":"Y Miyamoto","year":"2003","unstructured":"Miyamoto, Y., Oho, K., Kumamoto, M., Toyonaga, A. & Sata, M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J. Gastroenterol. Hepatol. 18, 934\u2013942 (2003).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"99855_CR28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/j.1440-1746.2010.06262.x","volume":"25","author":"M Kumamoto","year":"2010","unstructured":"Kumamoto, M. et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome. J. Gastroenterol. Hepatol. 25, 1129\u20131135 (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"99855_CR29","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jvir.2016.03.031","volume":"27","author":"A Yamamoto","year":"2016","unstructured":"Yamamoto, A. et al. Prediction for improvement of liver function after balloon-occluded retrograde transvenous obliteration for gastric varices to manage portosystemic shunt syndrome. J. Vasc. Interv. Radiol. 27, 1160\u20131167 (2016).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"99855_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00311993","volume":"26","author":"K Nishioka","year":"1996","unstructured":"Nishioka, K. et al. Extreme hyperbilirubinemia induced by endoscopic injection sclerotherapy in a patient with esophageal varices and thalassemia: Report of a case. Surg. Today 26, 53\u201356 (1996).","journal-title":"Surg. Today"},{"key":"99855_CR31","unstructured":"Japanese Research society for Portal Hypertension. The general rules for recording endoscopic findings of esophageal varices\u2014Revised edition. Acta Hepatol. Jpn. 33, 271\u2013281 (1991)."},{"key":"99855_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. & Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646\u2013649 (1973).","journal-title":"Br. J. Surg."},{"key":"99855_CR33","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"99855_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson, P. J. et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade. J. Clin. Oncol. 33, 550\u2013558 (2015).","journal-title":"J. Clin. Oncol."},{"key":"99855_CR35","doi-asserted-by":"crossref","unstructured":"Kamath, P. S., Kim, W. R., Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology 45, 797\u2013805 (2007).","DOI":"10.1002\/hep.21563"},{"key":"99855_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99855-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99855-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99855-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T04:10:07Z","timestamp":1699675807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99855-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99855"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99855-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"assertion":[{"value":"25 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20479"}}